Global University Venturing

Sema4, spun out of Icahn School of Medicine, has achieved a valuation of more than $1bn following a $121m series C round.

Osaka University Venture Capital was among the investors in a series D round for Kyorin University-founded cancer treatment developer J-Pharma.

Italian tech transfer fund Eureka has attracted an initial $44.9m from LPs including ItaTech as well as Umbra and Saes to invest in spinouts from domestic institutions.

Funding for HUJ spinouts remained stable during the first six months of 2020 as the Israeli VC sector showed signs of resilience amid Covid-19.

Drug protein discovery company Bright Peak hopes to deliver conjugated cancer immunotherapies based on an ETH Zürich-invented platform.

University of Louisville, University of Kentucky and Kentucky Science and Technology will extend their tech transfer expertise to other local institutions.

Co-founded by faculty from Columbia University and University of Melbourne, Praxis Precision Medicines targets CNS disorders.

University of Utah spinout Vaporsens has been acquired by Gentex for $10.5m after the corporate had already supplied $3m in equity financing.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.

CureVac has filed for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.